Characteristics | Number (%) of patients | |
---|---|---|
Age (approximately at consent) | Â | Â |
 Median (range) | 64.5 | (34–81 years) |
Gender | Â | Â |
 Male | 14 | 54% |
 Female | 12 | 46% |
ECOG performance status | Â | Â |
 ECOG 0 | 8 | 31% |
 ECOG 1 | 18 | 69% |
Primary tumour types | Â | Â |
 Colorectal cancer | 8 | 31% |
 Endometrial cancer | 3 | 12% |
 Small intestine cancer | 3 | 12% |
 Stomach cancer | 3 | 12% |
 Bile duct cancer | 3 | 12% |
 Breast cancer | 2 | 8% |
 Pancreatic cancer | 1 | 4% |
 Prostate cancer | 1 | 4% |
 Neuroendocrine cancer | 1 | 4% |
 Glioblastoma | 1 | 4% |
Number of prior systemic therapy linesa | Â | Â |
 No previous lines | 1 | 4% |
 1 previous line | 10 | 38% |
 2 previous lines | 7 | 27% |
  ≥ 3 previous lines | 8 | 31% |
Lynch syndrome | 8 | 33% |